FibroBiologics, Inc. (NASDAQ:FBLG – Get Free Report) traded up 16% during trading on Thursday . The company traded as high as $11.75 and last traded at $11.01. 78,924 shares were traded during mid-day trading, a decline of 24% from the average session volume of 104,478 shares. The stock had previously closed at $9.49.
FibroBiologics Trading Up 16.0 %
The firm has a 50 day moving average price of $11.36.
About FibroBiologics
FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds 150+ U.S. and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer.
See Also
- Five stocks we like better than FibroBiologics
- What is the Australian Securities Exchange (ASX)
- Comprehensive PepsiCo Stock Analysis
- 3 REITs to Buy and Hold for the Long Term
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- 3 Fintech Stocks With Good 2021 Prospects
- Bear Market Funds to Watch This Year
Receive News & Ratings for FibroBiologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FibroBiologics and related companies with MarketBeat.com's FREE daily email newsletter.
